This presentation was originally reviewed on December 13, 2023, and broadcast live online on December 13, 2023, from 12:00 PM – 1:00 PM ET.

Over the past few decades, advances in the neurosciences have led to exciting opportunities to correlate subjective symptom reports with objective measures using imaging and neuroendocrine markers. It is well established that psychotherapy has biological effects on reshaping maladaptive neuronal responses, leading to more flexible activation patterns. This occurs in tandem with clinical response to successful psychological treatments, as patients may soften their rigid cognitions regarding self and others, allowing for more measured approaches to their conflicts. It can be difficult to assimilate the expansive literature on this topic, making it hard to know what information is relevant and useful for practitioners. This presentation will distill how psychotherapy can lead to neurobiological change, linking its effect with the maladaptive activation patterns seen in common psychiatric conditions.

This presentation was originally reviewed on December 4, 2023, and broadcast live online on December 6, 2023, from 12:00 PM – 1:00 PM ET.

This presentation was originally reviewed on April 19, 2022, and broadcast live online on April 20, 2022, from 12:00 PM – 1:00 PM ET.

Frank Sinatra (1915-1998) was among the most admired and influential performing artists of the 20th century, with an approach to rhythm and phrasing that left a deep and lasting impression on all popular singers to follow. At the same time, his public persona and private life were among the most controversial of public figures. This presentation will use images, audio, and video clips to illustrate Mr. Sinatra’s professional journey across six decades, including examination of his lifelong alcohol use and periods of despondency and suicidality. We will pay special attention to how he dealt with his own aging process, including how he continued to tour in concert well into the progressive dementia that would eventually end his career. His story holds rich implications for considering the creative resilience potential in aging, and for the limitations to such resilience posed by illness and functional impairment.

Behavioral and Psychological Symptoms of Dementia (BPSD) refers to a group of non-cognitive symptoms and behaviors that occur commonly in patients with dementia. They result from a complex interplay between various biological, psychological and social factors involved in the disease process. BPSD is associated with increased caregiver burden, institutionalization, a more rapid decline in cognition and function and overall poorer quality of life. It also adds to the direct and indirect costs of caring for patients with dementia. Available data indicate efficacy for some non-pharmacological and pharmacological treatment modalities for BPSD. However, recently the use of psychotropic medications for the treatment of BPSD has generated controversy due to increased recognition of their serious adverse effects.

It is estimated that approximately 280 - 350 million people in the world suffer from depression and is the leading cause of disability around the world. Treatment response and remission do not occur in every patient treated for depression and have led to the use of the term treatment resistant depression (TRD). This talk will review the model of treatment resistant depression, its limitations and offer a view through a difficult to treat depression model. This talk will also focus on the importance of thorough assessment as well as current and future treatments.

This presentation was originally reviewed on March 21, 2022, and broadcast live online on March 23, 2022, from 11:30 AM – 1:00 PM ET.

This presentation was originally reviewed on April 5, 2022, and broadcast live online on April 6, 2022, from 12:00 PM – 1:00 PM ET.

This presentation was originally reviewed on October 10, 2022, and broadcast live online on October 12, 2023, from 11:30 AM – 1:00 PM ET.